Immune checkpoint inhibitor-induced refractory polyarthritis rapidly improved by sarilumab and monitoring with joint ultrasonography: A case report

RATIONALE: Immune checkpoint inhibitors (ICIs) have shown efficacy for the treatment of various kinds of malignant tumors. However, ICIs can cause immune-related adverse events, such as arthritis. Nevertheless, the treatment of ICI-induced arthritis has not been established yet. Here we report a cas...

Descripción completa

Detalles Bibliográficos
Autores principales: Abe, Kazuya, Ishikawa, Yuichi, Fujiwara, Michio, Yukawa, Hiroko, Yanagihara, Takeshi, Takei, Saori, Arioka, Hitoshi, Kita, Yasuhiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
6900
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8758007/
https://www.ncbi.nlm.nih.gov/pubmed/35029182
http://dx.doi.org/10.1097/MD.0000000000028428

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8758007/
https://www.ncbi.nlm.nih.gov/pubmed/35029182
http://dx.doi.org/10.1097/MD.0000000000028428

Ejemplares similares